Target intelligence / Profile preview

Glutathione S-transferase Mu 4 (GSTM4)

Target
GSTM4
Molecular classification
Enzyme, Phase II detoxification enzyme, Transferase (specifically glutathione S-transferase, mu class)
01

Overview

Glutathione S-transferase Mu 4 (GSTM4) is a cytosolic enzyme of the mu class, encoded by the GSTM4 gene located on chromosome 1p13.3[1][3][8]. It catalyzes the conjugation of reduced glutathione to a diverse array of endogenous and exogenous electrophilic compounds, including drugs, carcinogens, and products of oxidative stress, facilitating their detoxification[1][3][4][5]. GSTM4 plays important roles in cellular protection, drug metabolism, and regulation of inflammatory mediators such as leukotriene C4, which may influence susceptibility and outcomes in diseases like cancer and inflammation[1][3][4][5][8]. Its gene displays polymorphism, leading to individual differences in toxin and drug metabolism. GSTM4 interacts with multiple drugs and is implicated in chemoresistance and differential drug responses[1][3][5].

Other names
GST class-mu 4GST-Mu2GSTM4-4Leukotriene C4 synthase GSTM4GTM4S-(hydroxyalkyl)glutathione lyase M4glutathione S-alkyltransferase M4glutathione S-aralkyltransferase M4glutathione S-aryltransferase M4glutathione S-transferase M4testis tissue sperm-binding protein Li 60n
02

Mechanism of action

Conjugates reduced glutathione to hydrophobic electrophiles, facilitating their excretion and detoxification[1][3][4][5]\nInhibition of GSTM4 reduces detoxification and may sensitize cancer cells to chemotherapeutics[5]

03

Biological functions

Detoxification of electrophilic compounds (e.g., carcinogens, drugs, environmental toxins) via glutathione conjugationProtection against oxidative stressMetabolism of xenobiotics and endogenous compoundsAnti-inflammatory actions (e.g., catalyzing formation of bioactive lipid mediators like maresin conjugate in tissue regeneration 1)
04

Disease associations

Cancer (impacting drug metabolism, susceptibility, and toxicity)Inflammation (related to leukotriene synthesis and anti-inflammatory lipid mediators)Barrett’s adenocarcinomaTremor, hereditary essential, 4
05

Safety considerations

Genetic polymorphisms can lead to variable drug metabolism, efficacy, and toxicityAltered GSTM4 activity may impact clearance of toxic compounds and response to chemotherapeutic agents; overexpression may confer chemotherapy resistance
06

Interacting drugs

Glutathione

8 more in the full profile.

07

Biomarkers

GSTM4 expression or genetic polymorphisms as markers of susceptibility to environmental toxins and drug response in cancer therapy

Beyond the preview

Go deeper on Glutathione S-transferase Mu 4 (GSTM4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione S-transferase Mu 4 (GSTM4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call